Drug intelligence / Profile preview

human amnion allograft

Development stage
Unknown
Lead developer
MIMEDX
Modality
Implantable Hydrogels → Hydrogel Systems → Drug Delivery Systems, Tissue Cells → Other Cell Types → Cell Therapies, Implantable Devices → Device-based Delivery → Drug Delivery Systems, Recombinant Proteins and Enzymes, Injectable Hydrogels → Hydrogel Systems → Drug Delivery Systems
Administration
Topical, Ophthalmic, Surgical Implant, Intraarticular
01

Overview

Human amnion allograft is a biologic tissue graft derived from the innermost layer of the placenta (the amniotic membrane), typically harvested after cesarean section births from healthy donors. The tissue is processed—either cryopreserved or dehydrated—to preserve its extracellular matrix and bioactive proteins. Human amnion allografts are rich in growth factors (such as basic fibroblast growth factor and epidermal growth factor), cytokines, collagen, fibronectin, hyaluronic acid, and anti-inflammatory proteins like interleukin-1 receptor antagonist. These properties confer anti-inflammatory, antimicrobial, antifibrotic effects and promote angiogenesis and cellular migration/proliferation. The primary mechanism of action is to provide a biocompatible scaffold that supports wound healing by facilitating granulation tissue formation and modulating inflammation. Human amnion allografts are used as wound covers or biological barriers for acute/chronic wounds (e.g., diabetic foot ulcers), burns, ophthalmic surface disorders (e.g., neurotrophic keratitis), periodontal regeneration in dentistry, tendon repair applications in orthopedics/trauma surgery—and are being studied for additional regenerative medicine indications[2][3][5][6][7][8][10].

Brand names
AmnioRepairEPIFIXAmnioGraftProKeraAmbioDisk
Other names
human amniotic membrane allograftHAM allograftdehydrated human amnion/chorion membrane allograftdHACM

Beyond the preview

Go deeper on human amnion allograft.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on human amnion allograft.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call